PHARMACOLOGY FINAL EXAM RASMUSSEN NEWEST 2026
ACTUAL EXAM 200 QUESTIONS AND CORRECT DETAILED
ANSWERS WITH RATIONALES (VERIFIED ANSWERS)
|ALREADY GRADED A+
1|Page
,PHARMACOLOGY FINAL EXAM
2026/2027 Examination
Total Questions: 200
Instructions:
• Answer all questions.
• Select the single best answer.
• Each question has four answer choices: A, B, C, and D.
• Select only ONE answer for each question.
SECTION 1: Pharmacokinetics and Pharmacodynamics
Questions 1–25
Q1. A nurse is reviewing the pharmacokinetic profile of a newly prescribed medication for a
client with hepatic cirrhosis. Which phase of pharmacokinetics is primarily impaired in this client?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: C. Metabolism
Rationale: The liver is the primary site of drug metabolism through the cytochrome P450 enzyme
system. Cirrhosis impairs hepatic function, reducing first-pass metabolism and prolonging the half-
life of medications. While distribution may be affected by altered protein binding, metabolism is the
most directly and significantly impacted phase in hepatic impairment.
Q2. A client is prescribed a medication that is 95% protein-bound. The client's serum albumin
level is 2.1 g/dL. The nurse should anticipate which alteration in drug response?
A. Decreased pharmacological effect due to reduced free drug
B. Increased risk of toxicity due to elevated free drug levels
C. Prolonged elimination half-life due to enhanced protein binding
D. Reduced absorption from the gastrointestinal tract
Correct Answer: B. Increased risk of toxicity due to elevated free drug levels
Rationale: Highly protein-bound drugs rely on albumin for transport. When albumin is low, fewer
binding sites are available, resulting in more free (unbound) and pharmacologically active drug. This
increases the risk of adverse effects and toxicity. The other options incorrectly describe the
relationship between protein binding and drug activity.
2|Page
, Q3. A nurse administers a drug with a half-life of 8 hours. Approximately how long will it take for
the drug to reach steady-state concentration with repeated dosing?
A. 8 hours
B. 16 hours
C. 32 hours
D. 64 hours
Correct Answer: C. 32 hours
Rationale: Steady state is typically achieved after approximately 4 to 5 half-lives. For a drug with
an 8-hour half-life, steady state occurs in approximately 32 to 40 hours (4 × 8 = 32). At steady state,
the rate of drug administration equals the rate of elimination.
Q4. A client receiving oral morphine reports inadequate pain relief. The nurse explains that a
significant portion of the drug is inactivated before reaching systemic circulation. Which
phenomenon accounts for this?
A. Protein binding
B. First-pass effect
C. Blood-brain barrier exclusion
D. Renal tubular reabsorption
Correct Answer: B. First-pass effect
Rationale: The first-pass effect occurs when orally administered drugs are absorbed through the
gastrointestinal tract and transported to the liver via the portal vein, where a substantial portion is
metabolized before reaching systemic circulation. This reduces bioavailability and explains why some
medications require higher oral doses or alternative routes.
Q5. A drug has a narrow therapeutic index. Which nursing intervention is most critical when
administering this medication?
A. Administering the drug with food to enhance absorption
B. Monitoring serum drug levels closely and assessing for toxicity
C. Giving the medication only once daily to minimize accumulation
D. Diluting the medication in a large volume of IV fluid
Correct Answer: B. Monitoring serum drug levels closely and assessing for toxicity
Rationale: A narrow therapeutic index means the difference between therapeutic and toxic
doses is very small. Medications such as digoxin, warfarin, and lithium require close serum level
monitoring and vigilant assessment for signs of toxicity. Small changes in dose or serum
concentration can lead to serious adverse effects.
Q6. A nurse is caring for a client receiving a competitive antagonist medication. Which effect
should the nurse expect?
3|Page
, A. The drug binds to the receptor and produces a maximal response
B. The drug binds to the receptor and prevents the agonist from producing its effect
C. The drug increases the number of available receptors
D. The drug enhances the natural neurotransmitter's action
Correct Answer: B. The drug binds to the receptor and prevents the agonist from producing its
effect
Rationale: A competitive antagonist binds to the same receptor site as the agonist but does not
activate the receptor, thereby blocking the agonist's effect. The antagonism can be overcome by
increasing the concentration of the agonist. Examples include naloxone (opioid antagonist) and
flumazenil (benzodiazepine antagonist).
Q7. Which statement accurately describes the concept of drug potency?
A. Potency is the maximum effect a drug can produce regardless of dose
B. Potency refers to the amount of drug required to produce a given effect
C. Potency is determined by the drug's elimination half-life
D. Potency is directly proportional to the drug's therapeutic index
Correct Answer: B. Potency refers to the amount of drug required to produce a given effect
Rationale: Potency describes the concentration or dose of a drug needed to produce a specific
effect. A more potent drug requires a lower dose to achieve the same response. Efficacy, in contrast,
is the maximum effect a drug can produce. Potency and efficacy are independent properties.
Q8. A client with renal impairment is prescribed a medication that is primarily excreted
unchanged by the kidneys. The nurse should anticipate which dosage adjustment?
A. Increased dose to compensate for rapid clearance
B. Decreased dose or extended dosing interval
C. No adjustment is necessary for renal impairment
D. Switching to a higher potency formulation
Correct Answer: B. Decreased dose or extended dosing interval
Rationale: Renal impairment reduces the clearance of drugs excreted unchanged by the kidneys,
leading to accumulation and increased risk of toxicity. Dosage reduction or interval extension is
necessary to maintain therapeutic levels without causing harm. The other options are inappropriate
for a client with impaired renal function.
Q9. Which phase of clinical trials involves testing a new drug on healthy volunteers to assess
safety and tolerability?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
4|Page
ACTUAL EXAM 200 QUESTIONS AND CORRECT DETAILED
ANSWERS WITH RATIONALES (VERIFIED ANSWERS)
|ALREADY GRADED A+
1|Page
,PHARMACOLOGY FINAL EXAM
2026/2027 Examination
Total Questions: 200
Instructions:
• Answer all questions.
• Select the single best answer.
• Each question has four answer choices: A, B, C, and D.
• Select only ONE answer for each question.
SECTION 1: Pharmacokinetics and Pharmacodynamics
Questions 1–25
Q1. A nurse is reviewing the pharmacokinetic profile of a newly prescribed medication for a
client with hepatic cirrhosis. Which phase of pharmacokinetics is primarily impaired in this client?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Correct Answer: C. Metabolism
Rationale: The liver is the primary site of drug metabolism through the cytochrome P450 enzyme
system. Cirrhosis impairs hepatic function, reducing first-pass metabolism and prolonging the half-
life of medications. While distribution may be affected by altered protein binding, metabolism is the
most directly and significantly impacted phase in hepatic impairment.
Q2. A client is prescribed a medication that is 95% protein-bound. The client's serum albumin
level is 2.1 g/dL. The nurse should anticipate which alteration in drug response?
A. Decreased pharmacological effect due to reduced free drug
B. Increased risk of toxicity due to elevated free drug levels
C. Prolonged elimination half-life due to enhanced protein binding
D. Reduced absorption from the gastrointestinal tract
Correct Answer: B. Increased risk of toxicity due to elevated free drug levels
Rationale: Highly protein-bound drugs rely on albumin for transport. When albumin is low, fewer
binding sites are available, resulting in more free (unbound) and pharmacologically active drug. This
increases the risk of adverse effects and toxicity. The other options incorrectly describe the
relationship between protein binding and drug activity.
2|Page
, Q3. A nurse administers a drug with a half-life of 8 hours. Approximately how long will it take for
the drug to reach steady-state concentration with repeated dosing?
A. 8 hours
B. 16 hours
C. 32 hours
D. 64 hours
Correct Answer: C. 32 hours
Rationale: Steady state is typically achieved after approximately 4 to 5 half-lives. For a drug with
an 8-hour half-life, steady state occurs in approximately 32 to 40 hours (4 × 8 = 32). At steady state,
the rate of drug administration equals the rate of elimination.
Q4. A client receiving oral morphine reports inadequate pain relief. The nurse explains that a
significant portion of the drug is inactivated before reaching systemic circulation. Which
phenomenon accounts for this?
A. Protein binding
B. First-pass effect
C. Blood-brain barrier exclusion
D. Renal tubular reabsorption
Correct Answer: B. First-pass effect
Rationale: The first-pass effect occurs when orally administered drugs are absorbed through the
gastrointestinal tract and transported to the liver via the portal vein, where a substantial portion is
metabolized before reaching systemic circulation. This reduces bioavailability and explains why some
medications require higher oral doses or alternative routes.
Q5. A drug has a narrow therapeutic index. Which nursing intervention is most critical when
administering this medication?
A. Administering the drug with food to enhance absorption
B. Monitoring serum drug levels closely and assessing for toxicity
C. Giving the medication only once daily to minimize accumulation
D. Diluting the medication in a large volume of IV fluid
Correct Answer: B. Monitoring serum drug levels closely and assessing for toxicity
Rationale: A narrow therapeutic index means the difference between therapeutic and toxic
doses is very small. Medications such as digoxin, warfarin, and lithium require close serum level
monitoring and vigilant assessment for signs of toxicity. Small changes in dose or serum
concentration can lead to serious adverse effects.
Q6. A nurse is caring for a client receiving a competitive antagonist medication. Which effect
should the nurse expect?
3|Page
, A. The drug binds to the receptor and produces a maximal response
B. The drug binds to the receptor and prevents the agonist from producing its effect
C. The drug increases the number of available receptors
D. The drug enhances the natural neurotransmitter's action
Correct Answer: B. The drug binds to the receptor and prevents the agonist from producing its
effect
Rationale: A competitive antagonist binds to the same receptor site as the agonist but does not
activate the receptor, thereby blocking the agonist's effect. The antagonism can be overcome by
increasing the concentration of the agonist. Examples include naloxone (opioid antagonist) and
flumazenil (benzodiazepine antagonist).
Q7. Which statement accurately describes the concept of drug potency?
A. Potency is the maximum effect a drug can produce regardless of dose
B. Potency refers to the amount of drug required to produce a given effect
C. Potency is determined by the drug's elimination half-life
D. Potency is directly proportional to the drug's therapeutic index
Correct Answer: B. Potency refers to the amount of drug required to produce a given effect
Rationale: Potency describes the concentration or dose of a drug needed to produce a specific
effect. A more potent drug requires a lower dose to achieve the same response. Efficacy, in contrast,
is the maximum effect a drug can produce. Potency and efficacy are independent properties.
Q8. A client with renal impairment is prescribed a medication that is primarily excreted
unchanged by the kidneys. The nurse should anticipate which dosage adjustment?
A. Increased dose to compensate for rapid clearance
B. Decreased dose or extended dosing interval
C. No adjustment is necessary for renal impairment
D. Switching to a higher potency formulation
Correct Answer: B. Decreased dose or extended dosing interval
Rationale: Renal impairment reduces the clearance of drugs excreted unchanged by the kidneys,
leading to accumulation and increased risk of toxicity. Dosage reduction or interval extension is
necessary to maintain therapeutic levels without causing harm. The other options are inappropriate
for a client with impaired renal function.
Q9. Which phase of clinical trials involves testing a new drug on healthy volunteers to assess
safety and tolerability?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
4|Page
